GE Capital will serve as the administrator of a $21.5 million investment into Amedica's spine device product development and growth.
Salt Lake City-based Amedica has developed a Silicon Nitride technology for orthopedic and spine implants that looks to promote bone on-growth and be a safe alternative to PEEK and titanium for interbody fusion.
GE's capital investment will help fund this and other device developments geared toward improving patient care and outcomes, according to the report.
More Articles on Spine Devices:
38 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
TranS1 Pays $6M to Settle Federal Investigation
Orthofix Launches CONSTRUX Spine Implant
GE's capital investment will help fund this and other device developments geared toward improving patient care and outcomes, according to the report.
More Articles on Spine Devices:
38 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
TranS1 Pays $6M to Settle Federal Investigation
Orthofix Launches CONSTRUX Spine Implant